Pediatr., 109, 984-988, 1986.
In this study, the team chose to investigate the role of a neurotransmitter called vasoactive intestinal peptide, as it has previously been linked to anti-inflammatory effects, meaning it could have a protective effect on disc tissue
This product is supplied for laboratory research and analytical reference use only
William Seeds explains what is happening in his book Peptide Protocols Volume 1: [AOD-9604] is unable to induce dimerization and thereby activation of the receptor (no competition with HGH) This fragment holds the fat-reducing and tissue repair sequence and mimics the effect of HGH on lipid metabolism, without having growth-promoting or pro-diabetic effects [AOD-9604] inhibits lipoprotein lipase activity in adipose tissue, stimulating lipolysis in adipocytes Since AOD-9604 does not interact with growth hormone receptors, it means the peptide has the following advantages over HGH: Does not increase IGF-1 production Does not induce insulin resistance Does not stimulate muscle growth Since beta-3-adrenergic receptor activation appears to be a secondary mechanism of the AOD-9604 peptide, its primary and complete mechanism for fat mobilization and/or fat cell death within adipose tissue is not currently known
Peptides like KPV and BPC-157 address the underlying immune dysfunction rather than just blocking histamine receptors
